Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic

HH Wu, Y Zhou, Y Tabata, JQ Gao - Journal of Controlled Release, 2019 - Elsevier
Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers
with a rational design have become increasingly popular in medical researches. Although …

Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: so near and yet so far

MY Thanuja, C Anupama, SH Ranganath - Advanced drug delivery reviews, 2018 - Elsevier
Cellular carriers for drug delivery are attractive alternatives to synthetic nanoparticles owing
to their innate homing/targeting abilities. Here, we review molecular interactions involved in …

Role of iodide metabolism in physiology and cancer

A De la Vieja, P Santisteban - Endocrine-related cancer, 2018 - erc.bioscientifica.com
Iodide (I−) metabolism is crucial for the synthesis of thyroid hormones (THs) in the thyroid
and the subsequent action of these hormones in the organism. I− is principally transported …

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment

C Spitzweg, PJ Nelson, E Wagner… - Endocrine-related …, 2021 - erc.bioscientifica.com
Cloning of the sodium iodide symporter (NIS) 25 years ago has opened an exciting chapter
in molecular thyroidology with the characterization of NIS as one of the most powerful …

Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice

C Kitzberger, K Shehzad, V Morath… - Molecular Therapy …, 2023 - cell.com
New treatment strategies are urgently needed for glioblastoma (GBM)—a tumor resistant to
standard-of-care treatment with a high risk of recurrence and extremely poor prognosis …

Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice

C Kitzberger, R Spellerberg, Y Han, KA Schmohl… - Clinical Cancer …, 2023 - AACR
Purpose: Mesenchymal stem cells (MSC) have emerged as cellular-based vehicles for the
delivery of therapeutic genes in cancer therapy based on their inherent tumor-homing …

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy

C Kitzberger, R Spellerberg, V Morath, N Schwenk… - EJNMMI research, 2022 - Springer
Cloning of the sodium iodide symporter (NIS) in 1996 has provided an opportunity to use
NIS as a powerful theranostic transgene. Novel gene therapy strategies rely on image …

Dual EGFR-and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma

R Spellerberg, T Benli-Hoppe, C Kitzberger… - Molecular Therapy …, 2022 - cell.com
Sodium iodide symporter (NIS) gene transfer for active accumulation of iodide in tumor cells
is a powerful theranostic strategy facilitating both diagnostic and therapeutic application of …

Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes

R Spellerberg, T Benli-Hoppe, C Kitzberger… - Molecular Therapy …, 2021 - cell.com
Lipo-oligomers, post-functionalized with ligands to enhance targeting, represent promising
new vehicles for the tumor-specific delivery of therapeutic genes such as the sodium iodide …

Integrin αvβ3-mediated effects of thyroid hormones on mesenchymal stem cells in tumor angiogenesis

KA Schmohl, AM Mueller, M Dohmann, R Spellerberg… - Thyroid, 2019 - liebertpub.com
Background: Several clinical and experimental studies have implicated thyroid hormones in
cancer progression. Cancer-relevant effects, including stimulation of tumor growth and new …